Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells

BACKGROUND: B-acute lymphoblastic leukemia (B-ALL) is derived from B cell progenitors. Recently, the development of appropriate combinations of chemotherapy and immunotherapy represents a promising approach for eliminating cancer. We previously constructed an anti-CD3 × anti-CD19 bi-specific antibod...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Dongmei, Li, Wei, Yang, Yuqi, Zhang, Xiaolong, Zhang, Qing, Yan, Yan, Yang, Ming, Wang, Jianxiang, Xiong, Dongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596481/
https://www.ncbi.nlm.nih.gov/pubmed/26444983
http://dx.doi.org/10.1186/s13045-015-0205-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596481/
https://www.ncbi.nlm.nih.gov/pubmed/26444983
http://dx.doi.org/10.1186/s13045-015-0205-6

Ejemplares similares